000 01509 a2200421 4500
005 20250516130701.0
264 0 _c20130423
008 201304s 0 0 eng d
022 _a0394-6320
024 7 _a10.1177/039463201202500412
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOu, J M
245 0 0 _aCombined blockade of AKT/mTOR pathway inhibits growth of human hemangioma via downregulation of proliferating cell nuclear antigen.
_h[electronic resource]
260 _bInternational journal of immunopathology and pharmacology
_c
300 _a945-53 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aApoptosis
650 0 4 _aCell Cycle
650 0 4 _aCell Proliferation
650 0 4 _aCells, Cultured
650 0 4 _aDown-Regulation
650 0 4 _aHemangioma
_xpathology
650 0 4 _aHumans
650 0 4 _aProliferating Cell Nuclear Antigen
_xgenetics
650 0 4 _aProto-Oncogene Proteins c-akt
_xantagonists & inhibitors
650 0 4 _aSignal Transduction
650 0 4 _aTOR Serine-Threonine Kinases
_xantagonists & inhibitors
700 1 _aQui, M-K
700 1 _aDai, Y-X
700 1 _aDong, Q
700 1 _aShen, J
700 1 _aDong, P
700 1 _aWang, X-F
700 1 _aLiu, Y-B
700 1 _aFei, Z-W
773 0 _tInternational journal of immunopathology and pharmacology
_gvol. 25
_gno. 4
_gp. 945-53
856 4 0 _uhttps://doi.org/10.1177/039463201202500412
_zAvailable from publisher's website
999 _c22401686
_d22401686